Fingerprint
Dive into the research topics of 'Correction to: A phase I study of LY3164530, a bispecific antibody targeting MET and EGFR, in patients with advanced or metastatic cancer (Cancer Chemotherapy and Pharmacology, (2018), 82, 3, (407-418), 10.1007/s00280-018-3623-7)'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically